MMJ Market Growth Continues as New Hampshire Passes Medical Cannabis Bill

Updated

MMJ Market Growth Continues as New Hampshire Passes Medical Cannabis Bill

SARASOTA, Fla.--(BUSINESS WIRE)-- As Neutra Corp. (OTCBB: NTRR) works to deliver new innovations to the U.S. medical marijuana industry, the market for those innovations continues to grow. Last week, lawmakers passed a bill to make New Hampshire the 19th state to approve medical marijuana (MMJ) prescriptions for patients with chronic or terminal illnesses.

The legislation will make New Hampshire the 19th state to legalize MMJ, in addition to the District of Columbia. Five more states have legislation pending to legalize prescriptions, according to ProCon.org.


NTRR CEO Sydney Jim praised the new legislation on Monday, predicting that more states would soon join New Hampshire in its legalization efforts. Many experts agree: The U.S. MMJ market could hit an estimated $1.7 billion in sales this year and is forecast to climb to $6 billion by 2018 by the Marijuana Business Factbook by MMJ Business Daily.

"About two dozen states introduced some type of cannabis legislation this year," Mr. Jim said. "If all or even most of the measures pass as this bill did in New Hampshire, the medical cannabis industry would benefit from hundreds of millions of dollars in new revenues."

NTRR plans to be well-positioned to capitalize on the incredible growth in the MMJ market in the coming years. Last month, the company formed a joint venture with Field of View Technologies to deliver cutting-edge innovations in smokeless delivery of medicinal cannabis. Soon after, NTRR signed a letter of intent with Vertigo Technologies, LLC, to market and develop products processes that could slash the time and work required to prepare medicinal cannabis for dispensary shelves.

By providing innovative products and services related to MMJ, Neutra Corp. plans to follow in the footsteps of other successful public companies, including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), enabling technological advancements in the cultivation and processing of cannabis in approved markets.

About Neutra Corp.

Neutra Corp. (www.neutracorp.com) is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.



Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com

KEYWORDS: United States North America Florida

INDUSTRY KEYWORDS:

The article MMJ Market Growth Continues as New Hampshire Passes Medical Cannabis Bill originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement